GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.830
+0.020 (0.71%)
At close: Nov 26, 2025, 4:00 PM EST
2.800
-0.030 (-1.06%)
After-hours: Nov 26, 2025, 6:59 PM EST
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $960.6 million as of November 26, 2025. Its market cap has decreased by -48.95% in one year.
Market Cap
960.60M
Enterprise Value
1.23B
1-Year Change
-48.95%
Ranking
Category
Stock Price
$2.83
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $960.60M, a decrease of -92.42%. That is a compound annual growth rate of -39.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 953.81M | -46.69% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
| Sep 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |